Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 investigator: Difference between revisions
From GxPlex
Gxplex admin (talk | contribs) m 1 revision imported |
imported>GxPlexBot Import from GxPlex Excel |
||
| Line 5: | Line 5: | ||
investigator | investigator | ||
|RefLanguage=EN | |RefLanguage=EN | ||
| | |RefTags=TAG-00018-Inv-die ++ TAG-00244-Def-ini ++ TAG-00193-Hea-Ang ++ TAG-00135-Inv-ntr | ||
| | |RefModule=2 | ||
| | |RefUnit=2.3.1 | ||
}} | }} | ||
| Line 15: | Line 15: | ||
|- | |- | ||
! colspan="2" class="gplx-infobox-header" | Reference Details | ! colspan="2" class="gplx-infobox-header" | Reference Details | ||
|- | |||
! Module | |||
| Module 2 β Unit 2.3.1 | |||
|- | |- | ||
! Scope | ! Scope | ||
| Line 32: | Line 35: | ||
| Β | | Β | ||
|- | |- | ||
! Tags | ! Tags | ||
| Β | | [[Glossary:TAG-00018-Inv-die|Investigator]], [[Glossary:TAG-00244-Def-ini|Definition]], [[Glossary:TAG-00193-Hea-Ang|Healthcare professional]], [[Glossary:TAG-00135-Inv-ntr|Trial site]] | ||
|- | |||
| Β | |||
|- | |||
| Β | |||
|- | |- | ||
! Comment | ! Comment | ||
Revision as of 17:29, 15 July 2026
| Document information | |
|---|---|
| Reference | GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 |
| Validity area | GBR |
| Scope(s) | HM |
| Document name | The Medicines for Human Use (Clinical Trials) Regulations 2004 |
| Version / Revision | 01-May-2004 |
| Status | Current |
| Document type | Legal act |
| Language(s) | EN |
| Description | The Medicines for Human Use (Clinical Trials) Regulations 2004 |
| Official source | Official link |
| Restricted access | No |
| Submitted by | Florian Adragna |
| Contributors | |
| Reference Details | |
|---|---|
| Module | Module 2 β Unit 2.3.1 |
| Scope | HM |
| Document part | Article 2
investigator |
| Language | EN |
| Original entry by | Florian Adragna |
| Contributors | |
| Tags | Investigator, Definition, Healthcare professional, Trial site |
| Comment | Definition of investigator in relation to a clinical trial |
Content
βinvestigatorβ means, in relation to a clinical trial, the authorised health professional responsible for the conduct of that trial at a trial site, and if the trial is conducted by a team of authorised health professionals at a trial site, the investigator is the leader responsible for that team;
